Year archive

Ab&B Bio-Tech CO., LTD. JS — 2025 filings

All 36 regulatory filings released by Ab&B Bio-Tech CO., LTD. JS (2627) in 2025, sourced directly from the official regulator.

36 Filings

2025 Period

2025 filings (36)

Filing	Released	Lang
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-12-23	English
(1) POLL RESULTS OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2025 (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND (3) CHANGE OF MEMBERS OF BOARD COMMITTEES Declaration of Voting Results & Voting Rights Announcements	2025-12-23	English
VOLUNTARY ANNOUNCEMENT - COMMENCEMENT OF PHASE III CLINICAL TRIAL FOR LYOPHILIZED HUMAN RABIES VACCINE (HUMAN DIPLOID CELL) Regulatory Filings	2025-12-08	English
FORM OF PROXY FOR THE SECOND EXTRAORDINARY GENERAL MEETING OF 2025 TO BE HELD ON TUESDAY, DECEMBER 23, 2025 AND ANY ADJOURNMENT THEREOF Proxy Solicitation & Information Statement	2025-12-04	English
(1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) RE-APPOINTMENT OF AUDITORS AND (3) NOTICE OF EGM Proxy Solicitation & Information Statement	2025-12-04	English
NOTICE OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2025 Proxy Solicitation & Information Statement	2025-12-04	English
(I) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (II) NOMINATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (III) CHANGE OF BOARD COMMITTEE MEMBERS Board/Management Information	2025-12-04	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025 Regulatory Filings	2025-12-01	English
VOLUNTARY ANNOUNCEMENT - COMMENCEMENT OF PHASE I CLINICAL TRIAL FOR ADJUVANTED QUADRIVALENT SUBUNIT INFLUENZA VACCINE AND ADJUVANTED TRIVALENT SUBUNIT INFLUENZA VACCINE Regulatory Filings	2025-11-13	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025 Regulatory Filings	2025-11-04	English
INSIDE INFORMATION - APPLICATION FOR THE H SHARE FULL CIRCULATION BY THE COMPANY Share Issue/Capital Change	2025-10-15	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025 Regulatory Filings	2025-10-02	English
Notification Letter to Non-registered Holders of H Shares and Request Form - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-09-29	English
Notification Letter to Registered H Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-09-29	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-29	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF OUR APPLICATION FOR QUADRIVALENT SUBUNIT INFLUENZA VACCINE BY THE NMPA Regulatory Filings	2025-09-03	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025 Regulatory Filings	2025-09-03	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-28	English
VOLUNTARY ANNOUNCEMENT - IND APPROVALS BY CHINA CDE AND U.S. FDA FOR RECOMBINANT RSV VACCINE (CHO CELL) (ADJUVANTS) Regulatory Filings	2025-08-17	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-15	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2025-08-13	English
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Share Issue/Capital Change	2025-08-08	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-08-08	English
Terms of Reference - Nomination Committee Governance Information	2025-08-08	English
Terms of Reference - Remuneration and Appraisal Committee Governance Information	2025-08-08	English
Terms of Reference - Audit Committee Governance Information	2025-08-08	English
ARTICLES OF ASSOCIATION Governance Information	2025-08-08	English
POSTPONEMENT OF EXPECTED TIMETABLE OF THE GLOBAL OFFERING DUE TO BAD WEATHER Share Issue/Capital Change	2025-08-05	English
Documents on Display Regulatory Filings	2025-07-31	English
GLOBAL OFFERING Share Issue/Capital Change	2025-07-31	English
GLOBAL OFFERING Capital/Financing Update	2025-07-31	English
PHIP (1st submission) Share Issue/Capital Change	2025-07-27	English
PHIP (1st submission) Audit Report / Information	2025-07-27	English
OC Announcement - Appointment Regulatory Filings	2025-07-24	English
Application Proof (1st submission) Audit Report / Information FY 2023	2025-07-24	English
Application Proof (1st submission) Regulatory Filings	2025-07-24	English